A detailed history of Corton Capital Inc. transactions in Natera, Inc. stock. As of the latest transaction made, Corton Capital Inc. holds 1,916 shares of NTRA stock, worth $391,400. This represents 0.81% of its overall portfolio holdings.

Number of Shares
1,916
Previous 1,811 5.8%
Holding current value
$391,400
Previous $305,000 0.98%
% of portfolio
0.81%
Previous 0.38%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$133.66 - $181.11 $14,034 - $19,016
105 Added 5.8%
1,916 $308,000
Q2 2025

Aug 05, 2025

SELL
$132.23 - $171.87 $49,718 - $64,623
-376 Reduced 17.19%
1,811 $305,000
Q1 2025

May 07, 2025

SELL
$132.63 - $177.0 $22,149 - $29,559
-167 Reduced 7.09%
2,187 $309,000
Q4 2024

Feb 13, 2025

BUY
$117.67 - $174.0 $80,368 - $118,842
683 Added 40.87%
2,354 $372,000
Q3 2024

Nov 14, 2024

SELL
$97.75 - $129.67 $310,063 - $411,313
-3,172 Reduced 65.5%
1,671 $212,000
Q2 2024

Aug 14, 2024

BUY
$85.28 - $112.6 $413,011 - $545,321
4,843 New
4,843 $524,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $19.8B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Corton Capital Inc. Portfolio

Follow Corton Capital Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Corton Capital Inc., based on Form 13F filings with the SEC.

News

Stay updated on Corton Capital Inc. with notifications on news.